Breast Cancer Assessment of DAWNA-1 and Fulvestrant Combination Therapy in Advanced Breast Cancer Patients: Phase 3 Trial Apr 20, 2023
Breast Cancer Treating ER+/HER2- Advanced Breast Cancer in Asian Women: Palbociclib and Letrozole PALOMA-4 Phase 3 Study Apr 20, 2023
Breast Cancer,HER2+ Phase 3 PRECIOUS Study: Pertuzumab Retreatment Benefits for HER2+ Cancer Patients Mar 28, 2023
Breast Cancer,HER2- Comparison of PAL + FUL vs. CAPE in the GEICAM/2013-02 (PEARL) Phase 3 Trial Mar 28, 2023
Breast Cancer,HER2- Cardiac Impact: Trastuzumab Emtansine vs Paclitaxel+Trastuzumab for HER2+ Breast Cancer Mar 27, 2023
Breast Cancer,HER2+ Fam-Trastuzumab Gains FDA Approval for HER2-Low Breast Cancer Treatment Mar 14, 2023
Breast Cancer,HER2+ HER2DX Test Correlates with Trastuzumab/Pertuzumab Therapy in HER2+/HR+ Breast Cancer Mar 14, 2023
